Curcumin-Etoposide Synergy: Unveiling the Molecular Mechanisms of Enhanced Apoptosis and Chemoresistance Attenuation in Breast Cancer DOI Creative Commons
Bahar Jaberian Asl, Reza Afarin, Mahdi Hatami

и другие.

Deleted Journal, Год журнала: 2024, Номер 23(1)

Опубликована: Ноя. 5, 2024

Combining natural compounds with chemotherapeutic agents has emerged as a promising approach for cancer treatment. Curcumin (Cur), polyphenol, is known its anti-cancer properties, including the ability to induce apoptosis and arrest cell cycle progression. This study aimed evaluate effects of Cur etoposide (ETO), both individually in combination, on induction breast (BC) lines. The impact ETO proliferation was assessed using MTT viability assays. Apoptosis by these drugs evaluated through Annexin V flow cytometry caspase-3 caspase-9 activity Quantitative real-time PCR employed measure Bax Bcl-2 gene expression levels. Western blotting conducted determine protein levels p53, p21, Bax, Bcl-2. A non-significant dose selected based assay results combined 75 µM Cur. enhanced ETO's pro-apoptotic effect increasing caspase activities. combination significantly reduced while upregulating expression. Furthermore, treatment this elevated compared or alone, decreasing potential amplify ETO-induced BC cells. may offer therapeutic BC.

Язык: Английский

In vitro Evaluation of a pH-sensitive PCL-PAMAM G4 Nanocarrier for Co-Delivery of Silver Nanoparticles and Quercetin in MCF-7 Breast Cancer Cells DOI
Mohammad Hadi Baghersad, Ali Salimi

Journal of Molecular Structure, Год журнала: 2025, Номер unknown, С. 141524 - 141524

Опубликована: Янв. 1, 2025

Язык: Английский

Процитировано

0

Ciprofloxacin-encapsulated solid lipid nanoparticles: a comprehensive biochemical analysis of cytotoxic effects, proliferation inhibition, and apoptotic induction in KG1-a leukemia cells DOI

S. Kadhim,

Gholamreza Dehghan, Majid Mahdavi

и другие.

Medical Oncology, Год журнала: 2025, Номер 42(3)

Опубликована: Фев. 13, 2025

Язык: Английский

Процитировано

0

Emerging phytochemical-based nanocarriers: redefining the perspectives of breast cancer therapy DOI
Gulshan Sharma,

Rohil Panwar,

Sangeeta Saini

и другие.

Naunyn-Schmiedeberg s Archives of Pharmacology, Год журнала: 2025, Номер unknown

Опубликована: Март 26, 2025

Язык: Английский

Процитировано

0

Hyaluronic acid-functionalized carboxymethyl dextran-coated melatonin nanoconjugates for targeted etoposide delivery in metastatic colon cancer: Extensive in-vitro investigation in HCT116 cell lines, antimicrobial efficacy, and anti-angiogenic potential in chick chorioallantoic membrane (CAM) assay DOI
Sankha Bhattacharya, Harshvardhan Raval, Darshan Bhirud

и другие.

International Journal of Biological Macromolecules, Год журнала: 2024, Номер 281, С. 136373 - 136373

Опубликована: Окт. 11, 2024

Язык: Английский

Процитировано

1

Shaping the future of medicine through diverse therapeutic applications of tetralin derivatives DOI

Bhumi Shah,

Radhika Kachhadiya

Medicinal Chemistry Research, Год журнала: 2024, Номер unknown

Опубликована: Ноя. 5, 2024

Язык: Английский

Процитировано

0

Formulation of Morus alba extract loaded Solid Lipid Nanoparticles: In Silico , Characterizations, and In vitro cytotoxicity study DOI
Narahari N. Palei,

Mohanalakshmi Sabapati,

S. Vijayaraj

и другие.

Drug Development and Industrial Pharmacy, Год журнала: 2024, Номер unknown, С. 1 - 15

Опубликована: Дек. 9, 2024

Objective This study aimed to formulate Morus alba leaf extract (MAE) loaded solid lipid nanoparticles (SLNs) and investigate its cytotoxic potential using MDA-MB231 cell line.Significance: SLNs can protect MAE from degradation, enhance cytotoxicity potential, making them suitable for various therapeutic areas.

Язык: Английский

Процитировано

0

Curcumin-Etoposide Synergy: Unveiling the Molecular Mechanisms of Enhanced Apoptosis and Chemoresistance Attenuation in Breast Cancer DOI Creative Commons
Bahar Jaberian Asl, Reza Afarin, Mahdi Hatami

и другие.

Deleted Journal, Год журнала: 2024, Номер 23(1)

Опубликована: Ноя. 5, 2024

Combining natural compounds with chemotherapeutic agents has emerged as a promising approach for cancer treatment. Curcumin (Cur), polyphenol, is known its anti-cancer properties, including the ability to induce apoptosis and arrest cell cycle progression. This study aimed evaluate effects of Cur etoposide (ETO), both individually in combination, on induction breast (BC) lines. The impact ETO proliferation was assessed using MTT viability assays. Apoptosis by these drugs evaluated through Annexin V flow cytometry caspase-3 caspase-9 activity Quantitative real-time PCR employed measure Bax Bcl-2 gene expression levels. Western blotting conducted determine protein levels p53, p21, Bax, Bcl-2. A non-significant dose selected based assay results combined 75 µM Cur. enhanced ETO's pro-apoptotic effect increasing caspase activities. combination significantly reduced while upregulating expression. Furthermore, treatment this elevated compared or alone, decreasing potential amplify ETO-induced BC cells. may offer therapeutic BC.

Язык: Английский

Процитировано

0